Curran, Ashley M. http://orcid.org/0000-0001-7735-0437
Naik, Pooja
Giles, Jon T.
Darrah, Erika http://orcid.org/0000-0003-1119-0279
Article History
Accepted: 12 March 2020
First Online: 27 April 2020
Competing interests
: E.D. and J.T.G. declare that they are authors on licensed patent no. 8,975,033 entitled “Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases”. E.D. declares that she is an author on provisional patent no. 62/481,158 entitled “Anti-PAD2 antibody for treating and evaluating rheumatoid arthritis”. E.D. has received grants from Bristol-Myers Squibb, Celgene and Pfizer, and personal fees from Celgene that are not related to this article. A.M.C. and P.N. declare no competing interests.